Records containing: Hepatocellular Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2023-01-26A Study on the Efficiency and Safety of Durvalumab Plus Lenvatinib as First-line Treatment for Unresectable Hepatocellular Carcinoma: an Open, Single Arm, Phase II Clinical Trial
-
CLINICAL_TRIALS study record update · 2023-01-23GastroIntestinal Cancer in Children and Adolescents (GICCA): a SEER Population-based Study
-
CLINICAL_TRIALS study record update · 2023-01-17An Open, Single Arm,Multicenter Clinical Trial of Anlotinib Combined With Transcatheter Arterial Chemoembolization for Adjuvant Therapy in Patients With High Risk of Recurrence After Resection of Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2023-01-10A Phase 2, Open-Label Study With Orally Administered CVM-1118 and Sorafenib in Subjects With Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2023-01-10[68Ga]DOTATATE-PET/MRI in Hepatocellular Carcinoma to Assess the Feasibility of Targeted Radionuclide Therapy With Somatostatin Receptor Ligands
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2023-01-06The European NAFLD Registry
-
CLINICAL_TRIALS study record update · 2022-12-30A Phase 1b/2, Multicenter, Open-label, Basket Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Liver Tumors Alone and in Combination With Systemic Pembrolizumab in Phase 1b and to Evaluate the Efficacy and Safety of Intratumoral Talimogene Laherparepvec in Combination With Systemic Pembrolizumab to Treat Subjects With Advanced Solid Tumors in Phase 2 (MASTERKEY-318)
-
CLINICAL_TRIALS study record update · 2022-12-30Methylation Detection of KCNA3 and OTOP2 Genes in Plasma for the Auxiliary Diagnosis of Hepatocellular Carcinoma: a Clinical Trial
-
CLINICAL_TRIALS study record update · 2022-12-29A Real World Study of Regogfinib in the Treatment of Advanced Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2022-12-29Transarterial Chemoembolization Combined With Penpulimab and Anlotinib for Advanced Hepatocellular Carcinoma：A Nationwide Multicenter Prospective Real-world Study
-
CLINICAL_TRIALS study record update · 2022-12-29Transarterial Chemoembolization With Lipiodol-Idarubicin Emulsion in the Treatment of Hepatocellular Carcinoma: a Prospective, Multicenter, Real-world Study
-
CLINICAL_TRIALS study record update · 2022-12-29Transarterial Chemoembolization With Lipiodol-Idarubicin Emulsion Based On a Specific Ratio for Hepatocellular Carcinoma:a Prospective, Observational Study
-
CLINICAL_TRIALS study record update · 2022-12-27Diagnostic Accuracy of Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis
-
CLINICAL_TRIALS study record update · 2022-12-2268Ga-FAPI PET for Response Evaluation and Prognosis Prediction in Advanced Liver and Biliary Cancer Patients Treated With PD-1 Based Combination Therapy: A Head-to-head Comparison to 18F-FDG PET
-
CLINICAL_TRIALS study record update · 2022-12-15Transarterial RAdioembolization Versus ChemoEmbolization for the Treatment of HCC: A Multicenter Randomized Controlled Trial (TRACE Trial)
-
CLINICAL_TRIALS study record update · 2022-12-14Hepatocellular Carcinoma Under 3 cm Treated by Percutaneous Tumor Destruction: Multicentric Phase 2 Test Evaluating the Impact of Adjuvant Chemotherapy by Intra-arterial Infusion of Idarubicin-lipiodol on the Hepatic Recurrence
-
CLINICAL_TRIALS study record update · 2022-12-14Phase II Trial of Abemaciclib and Nivolumab for Subjects With Hepatocellular Carcinoma
-
CLINICAL_TRIALS study record update · 2022-12-14Peri-operative Vitamin D Therapy for Patients With Hepatocellular Carcinoma Receiving Hepatectomy
-
CLINICAL_TRIALS study record update · 2022-12-13PRIME-HCC: Preliminary Assessment of Safety and Bioactivity of the Ipilimumab and Nivolumab Combination Prior to Liver Resection (LR) in Hepatocellular Carcinoma (HCC)
-
CLINICAL_TRIALS study record update · 2022-12-09Hepatic Arterial Infusion With Oxaliplatin & 23h Fluorouracil Versus Hepatic Arterial Infusion With Oxaliplatin & 46h Fluorouracil for Unresectable Hepatocellular Carcinoma：a Non-inferiority Study
-
CLINICAL_TRIALS study record update · 2022-12-06A Pilot Study of Beta-Blockers in Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2022-12-05Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry
-
CLINICAL_TRIALS study record update · 2022-12-01A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®20717 in Subjects With Selected Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2022-11-30Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane
-
CLINICAL_TRIALS study record update · 2022-11-28Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases, in Children and Young Adults With Refractory Sarcomas, Wilms Tumor, and Other Rare Tumors